secwatch.observer — SEC 8-K summary
======================================

Issuer:     Skye Bioscience, Inc. (SKYE)
CIK:        0001516551
Form:       8-K
Filed at:   2023-11-07T23:59:59+00:00
Accession:  0001516551-23-000083
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Skye Bioscience increases authorized common shares from 20M to 100M
-------------------------------------------------------------------

- Filed Certificate of Amendment on Nov 6, 2023, raising authorized common shares from 20,000,000 to 100,000,000.
- No change to issued and outstanding shares; only affects potential future issuances.
- Board unanimously approved; majority stockholders consented in writing in lieu of a special meeting.
- Amendment provides additional flexibility for future capital raising or strategic transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1516551/000151655123000083/0001516551-23-000083-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1516551/000151655123000083/skye-20231106.htm
  HTML page:      https://secwatch.observer/filing/0001516551-23-000083

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer